文献速递神经儿科影像MR

早产儿促红细胞生成素刺激剂的长期影响:一项关于早期儿童神经代谢物的质子磁共振波谱研究

The long-term effect of erythropoiesis stimulating agents given to preterm infants: a proton magnetic resonance spectroscopy study on neurometabolites in early childhood.
PubMed 文献 · Pediatr Radiol · 2018-01-15

本研究对出生体重500-1,250 g的早产儿在新生儿期给予促红细胞生成素刺激剂(ESA)或安慰剂,并与健康足月对照比较,在约4岁和6岁时行质子磁共振波谱(1H-MRS)检测前扣带回和额叶白质代谢物。结果显示各组间任何代谢物水平均无显著差异(P≤0.5),白质tNAA和Cho随年龄显著增加,灰质tNAA有增加趋势。结论认为早产或新生儿ESA治疗与4-6岁时脑代谢物水平差异无关。

要点

  • 早产儿及新生儿ESA治疗组在4-6岁时脑代谢物水平与足月对照无显著差异。
  • 白质tNAA和Cho随年龄显著增加,灰质tNAA呈增加趋势。
  • 1H-MRS取前扣带回(灰质)和额叶白质,评估tNAA、肌醇、Cho、Cr+PCr、Glx。

核心结论

  • 早产或新生儿ESA治疗与4-6岁时脑代谢物水平差异无关(显著性水平0.05);早期可能存在的差异或已正常化,或在本样本中过小未达统计学显著。

研究设计与样本

  • 纵向神经发育研究的儿童在约4岁和6岁时接受MRI和1H-MRS;早产儿(出生体重500-1,250 g)在新生儿住院期间接受ESA(促红细胞生成素或达贝泊汀)或安慰剂,并与健康足月对照比较;从前往扣带回(灰质)和额叶白质获取波谱,评估tNAA、肌醇、Cho、Cr+PCr和Glx。

诊断标准与关键数值

  • 各组间任何代谢物水平均无显著差异(P≤0.5)。
  • 白质tNAA和Cho随年龄显著增加,灰质tNAA呈增加趋势。

局限性

  • 原文结论指出早期可能存在的差异或已正常化,或在本样本中过小未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Erythropoiesis stimulating agents (ESAs) are neuroprotective in cell and animal models of preterm birth. Prematurity has been shown to alter neurometabolite levels in children in studies using proton magnetic resonance spectroscopy (1H-MRS).

OBJECTIVE: We hypothesized that ESA treatment in premature infants would tend to normalize neurometabolites by 4-6 years of age.

MATERIALS AND METHODS: Children in a longitudinal study of neurodevelopment underwent MRI and 1H-MRS at approximately 4 years and 6 years of age. Prematurely born children (500-1,250 g birth weight) received ESAs (erythropoietin or darbepoetin) or placebo during their neonatal hospitalization, and these groups were compared to healthy term controls. 1H-MRS spectra were obtained from the anterior cingulate (gray matter) and frontal lobe white matter, assessing combined N-acetylaspartate and N-acetylaspartylglutamate (tNAA), myo-inositol, choline compounds (Cho), combined creatine and phosphocreatine, and combined glutamate and glutamine.

RESULTS: No significant (P≤0.5) group differences were observed for any metabolite level. Significant age-related increases in white-matter tNAA and Cho were observed, as well as a trend for increased gray-matter tNAA.

CONCLUSION: Neither prematurity nor neonatal ESA treatment was associated with differences in brain metabolite levels in the children of this study at a significance level of 0.05. These findings suggest that earlier differences that might have existed had normalized by 4-6 years of age or were too small to be statistically significant in the current sample.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Gasparovic C, Caprihan A, Yeo RA, et al. The long-term effect of erythropoiesis stimulating agents given to preterm infants: a proton magnetic resonance spectroscopy study on neurometabolites in early childhood. Pediatr Radiol. 2018. PMID: 29335880. doi:10.1007/s00247-017-4052-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。